Analyst Research

Report Title Price
Provider: GlobalData
Provider: Reuters Investment Profile
Provider: Sadif Analytics Prime
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biomerieux confirms FY 2014 sales guidance and updates on recent activities

Wednesday, 23 Apr 2014 01:00am EDT 

Biomerieux SA:Confirms FY 2014 objective of 3 - 5 pct organic sales growth.Says in conjunction with BioFire acquisition, wholly owned subsidiary (BioFire Defense, LLC) was created to focus on United States military contracts.In February, the United States Department of Defense (DoD) awarded BioFire Defense the $240 million Next Generation Diagnostic System (NGDS) Technology Development contract.Legal protest action has been initiated by another competing company and in accordance with Federal Acquisition Regulations, stop work order was received by BioFire Defense at end of March.BioFire Defense is working with government officials on this issue.Says in Q1 2014 Biomerieux introduced chromID CARBA SMART, new bi-plate Petri dish whose two selective chromogenic media make it possible to screen for all carbapenemase-producing Enterobacteriacae (CPE) in 18 to 24 hours.Says it decided not to pursue its collaboration with Philips aimed at developing a fully automated handheld diagnostic testing solutions for hospital use that can be deployed at point-of-care.Says it has established new two business units for its customer segments, Clinical Unit and Industry Unit. 

Company Quote

0.04 +0.05%
19 Dec 2014